These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23866736)

  • 1. Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberia.
    Schramm B; Valeh P; Baudin E; Mazinda CS; Smith R; Pinoges L; Sundaygar T; Zolia YM; Jones JJ; Comte E; Bruneel A; Branger M; Jullien V; Carn G; Kiechel JR; Ashley EA; Guérin PJ
    Malar J; 2013 Jul; 12():250. PubMed ID: 23866736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of artesunate-amodiaquine and artemether-lumefantrine fixed-dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria among children aged six to 59 months in Nimba County, Liberia: an open-label randomized non-inferiority trial.
    Schramm B; Valeh P; Baudin E; Mazinda CS; Smith R; Pinoges L; Dhorda M; Boum Y; Sundaygar T; Zolia YM; Jones JJ; Comte E; Houzé P; Jullien V; Carn G; Kiechel JR; Ashley EA; Guérin PJ
    Malar J; 2013 Jul; 12():251. PubMed ID: 23866774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated falciparum malaria in children: a multisite, open-label, two-cohort, clinical trial in Mozambique.
    Nhama A; Bassat Q; Enosse S; Nhacolo A; Mutemba R; Carvalho E; Naueia E; Sevene E; Guinovart C; Warsame M; Sanz S; Mussa A; Matsinhe G; Alonso P; Tiago A; Macete E
    Malar J; 2014 Aug; 13():309. PubMed ID: 25108397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized non-inferiority and safety trial of dihydroartemisin-piperaquine and artesunate-amodiaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroonian children.
    Nji AM; Ali IM; Moyeh MN; Ngongang EO; Ekollo AM; Chedjou JP; Ndikum VN; Evehe MS; Froeschl G; Heumann C; Mansmann U; Ogundahunsi O; Mbacham WF
    Malar J; 2015 Jan; 14():27. PubMed ID: 25626448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial.
    Ndiaye JL; Faye B; Gueye A; Tine R; Ndiaye D; Tchania C; Ndiaye I; Barry A; Cissé B; Lameyre V; Gaye O
    Malar J; 2011 Aug; 10():237. PubMed ID: 21838909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria.
    Ndiaye JL; Randrianarivelojosia M; Sagara I; Brasseur P; Ndiaye I; Faye B; Randrianasolo L; Ratsimbasoa A; Forlemu D; Moor VA; Traore A; Dicko Y; Dara N; Lameyre V; Diallo M; Djimde A; Same-Ekobo A; Gaye O
    Malar J; 2009 Jun; 8():125. PubMed ID: 19505304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of fixed-dose artesunate-amodiaquine vs. artemether-lumefantrine for repeated treatment of uncomplicated malaria in Ugandan children.
    Yeka A; Lameyre V; Afizi K; Fredrick M; Lukwago R; Kamya MR; Talisuna AO
    PLoS One; 2014; 9(12):e113311. PubMed ID: 25436614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial on effectiveness of artemether-lumefantrine versus artesunate plus amodiaquine for unsupervised treatment of uncomplicated Plasmodium falciparum malaria in Ghanaian children.
    Kobbe R; Klein P; Adjei S; Amemasor S; Thompson WN; Heidemann H; Nielsen MV; Vohwinkel J; Hogan B; Kreuels B; Bührlen M; Loag W; Ansong D; May J
    Malar J; 2008 Dec; 7():261. PubMed ID: 19099594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and safety of artemether-lumefantrine versus artesunate-amodiaquine for unsupervised treatment of uncomplicated falciparum malaria in patients of all age groups in Nanoro, Burkina Faso: a randomized open label trial.
    Sondo P; Derra K; Diallo-Nakanabo S; Tarnagda Z; Zampa O; Kazienga A; Valea I; Sorgho H; Owusu-Dabo E; Ouedraogo JB; Guiguemde TR; Tinto H
    Malar J; 2015 Aug; 14():325. PubMed ID: 26289949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.
    Otienoburu SD; Maïga-Ascofaré O; Schramm B; Jullien V; Jones JJ; Zolia YM; Houzé P; Ashley EA; Kiechel JR; Guérin PJ; Le Bras J; Houzé S
    Malar J; 2016 Sep; 15(1):452. PubMed ID: 27596849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up.
    Adjei GO; Kurtzhals JA; Rodrigues OP; Alifrangis M; Hoegberg LC; Kitcher ED; Badoe EV; Lamptey R; Goka BQ
    Malar J; 2008 Jul; 7():127. PubMed ID: 18620577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of artesunate-amodiaquine (Camoquin plus) versus artemether-lumefantrine (Coartem) against uncomplicated Plasmodium falciparum malaria: multisite trial in Senegal and Ivory Coast.
    Faye B; Offianan AT; Ndiaye JL; Tine RC; Touré W; Djoman K; Sylla K; Ndiaye PS; Penali L; Gaye O
    Trop Med Int Health; 2010 May; 15(5):608-13. PubMed ID: 20214761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated Plasmodium falciparum malaria in Malawi, 2014.
    Paczkowski M; Mwandama D; Marthey D; Luka M; Makuta G; Sande J; Ali D; Troell P; Mathanga DP; Gutman J
    Malar J; 2016 Apr; 15():236. PubMed ID: 27113085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized comparison of the efficacies and tolerabilities of three artemisinin-based combination treatments for children with acute Plasmodium falciparum malaria in the Democratic Republic of the Congo.
    Onyamboko MA; Fanello CI; Wongsaen K; Tarning J; Cheah PY; Tshefu KA; Dondorp AM; Nosten F; White NJ; Day NP
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5528-36. PubMed ID: 25001306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of artemether + lumefantrine, artesunate + sulphamethoxypyrazine-pyrimethamine and artesunate + amodiaquine and sulphadoxine-pyrimethamine + amodiaquine in the treatment of uncomplicated falciparum malaria in Bangui, Central African Republic: a randomized trial.
    Djallé D; Njuimo SP; Manirakiza A; Laganier R; Le Faou A; Rogier C
    Malar J; 2014 Jan; 13():9. PubMed ID: 24393479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the efficacy and safety of three 2-drug combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Senegal: artesunate-amodiaquine, dihydroartemisinin-piperaquine, and artemether-lumefantrine].
    Sow D; Ndiaye JL; Sylla K; Ba MS; Tine RC; Faye B; Pene M; Ndiaye M; Seck A; Lo AC; Abiola A; Dieng Y; Gaye O
    Med Sante Trop; 2016; 26(1):45-50. PubMed ID: 26644184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso.
    Lingani M; Bonkian LN; Yerbanga I; Kazienga A; Valéa I; Sorgho H; Ouédraogo JB; Mens PF; Schallig HDFH; Ravinetto R; d'Alessandro U; Tinto H
    Malar J; 2020 Jan; 19(1):8. PubMed ID: 31906948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and tolerability of artesunate-amodiaquine, artemether-lumefantrine and quinine plus clindamycin in the treatment of uncomplicated Plasmodium falciparum malaria in Kinshasa, the Democratic Republic of the Congo.
    Lula Ntamba Y; Muhindo Mavoko H; Kalabuanga M; Fungula B; Ntamabyaliro Nsengi PM; Tona Lutete G; Inocencio da Luz R; Van Geertruyden JP; Lutumba P
    PLoS One; 2019; 14(9):e0222379. PubMed ID: 31527899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open randomized controlled trial to compare the efficacy of two fixed dose combinations of artemesinin based combinations for uncomplicated falciparum malaria in Bangladesh.
    Samad R; Rahman MR; Yunus EB; Hussain MA; Arif SM; Islam MN; Hafiz SA; Hossain MM; Faiz MA
    Bangladesh Med Res Counc Bull; 2013 Dec; 39(3):109-15. PubMed ID: 26118157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.